POLDIP2 and breast carcinoma: Correlation matrix analysis with these 38 cell lines (Figure 5A) confirmed the clear co-regulatory pattern of the TNFAIP1/POLDIP2 SFGM, which was primarily identified in two breast cancer cohorts.